세계의 지혈제 및 조직 봉합제 시장 - 규모, 점유율, 성장 분석 : 제품별, 재료별, 용도별, 최종 사용자별, 지역별 산업 예측(2026-2033년)

Global Hemostasis and Tissue Sealing Agents Market size was valued at USD 8.01 Billion in 2024 and is poised to grow from USD 8.66 Billion in 2025 to USD 16.15 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The global market for hemostasis and tissue sealing agents is witnessing robust growth, fueled by the increasing incidence of chronic diseases and a rising elderly population, leading to heightened surgical demands. This surge necessitates effective hemostatic and sealing solutions to enhance patient safety and minimize complications. Innovations in surgical procedures, particularly minimally invasive techniques, further stimulate market expansion, with a growing dependence on reliable agents to secure successful outcomes. Manufacturers are prioritizing research and development to create advanced products with enhanced efficacy and fewer side effects, fostering greater acceptance among healthcare professionals. However, challenges persist, including stringent regulatory frameworks, cost constraints, and competitive pressures that impact market dynamics and profitability, necessitating ongoing investment in innovation and strategic positioning.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hemostasis and Tissue Sealing Agents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hemostasis and Tissue Sealing Agents Market Segments Analysis

Global Hemostasis and Tissue Sealing Agents Market is segmented by Product, Material, Application, End-use and region. Based on Product, the market is segmented into Topical Hemostats and Adhesive & Tissue Sealant. Based on Material, the market is segmented into Gelatin-based Topical Hemostats, Collagen-based Topical Hemostats, ORC-based Topical Hemostats and Polysaccharide-based Topical Hemostats. Based on Application, the market is segmented into General Surgery,Neurosurgery, Vascular Surgery, Cardiovascular Surgery and Others. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Home Care Settings and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hemostasis and Tissue Sealing Agents Market

The increasing inclination towards minimally invasive surgical methods has significantly elevated the need for specialized hemostatic and tissue sealing agents, particularly in laparoscopic, endoscopic, and robotic-assisted surgeries. These agents are essential for achieving effective hemostasis and ensuring secure tissue closure, thus enhancing surgical outcomes and patient recovery. As healthcare professionals continue to adopt these advanced surgical techniques, the demand for innovative solutions that support these procedures intensifies, driving the growth of the market for hemostatic and tissue sealing agents. This trend reflects a broader movement towards improving surgical efficiency and patient safety in modern medical practices.

Restraints in the Global Hemostasis and Tissue Sealing Agents Market

The entry of new hemostasis and tissue sealing agents into the market is often impeded by a lengthy and costly approval process, largely driven by stringent regulatory requirements. These rigorous protocols can pose significant challenges for manufacturers, resulting in delays in the commercialization of innovative products. Consequently, the potential for new agents to gain market traction is diminished as they navigate complex regulations, ultimately stifling competition and limiting options for healthcare providers and patients alike. As a result, the overall growth of the global hemostasis and tissue sealing agents market may be adversely affected.

Market Trends of the Global Hemostasis and Tissue Sealing Agents Market

The Global Hemostasis and Tissue Sealing Agents market is increasingly driven by a pronounced shift towards minimally invasive surgical techniques. This trend is propelled by the numerous benefits associated with such procedures, including smaller incisions, reduced scarring, and expedited recovery times. As medical professionals adopt these advanced techniques, the necessity for specialized hemostasis and tissue sealing solutions has surged, fostering innovation in product development. The growing emphasis on patient outcomes, coupled with advancements in materials and technologies, is reshaping the market landscape, resulting in an expanded portfolio of effective sealing agents tailored to the specific needs of minimally invasive surgeries.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Raw Material Analysis

Global Hemostasis and Tissue Sealing Agents Market Size by Product & CAGR (2026-2033)

• Market Overview
• Topical Hemostats
  • Active
  • Mechanical
  • Flowable
• Adhesive & Tissue Sealant
  • Synthetic Tissue Sealant
  • Natural Tissue Sealant
  • Adhesion Barrier Products

Global Hemostasis and Tissue Sealing Agents Market Size by Material & CAGR (2026-2033)

• Market Overview
• Gelatin-based Topical Hemostats
• Collagen-based Topical Hemostats
• ORC-based Topical Hemostats
• Polysaccharide-based Topical Hemostats

Global Hemostasis and Tissue Sealing Agents Market Size by Application & CAGR (2026-2033)

• Market Overview
• General Surgery
• Neurosurgery
• Vascular Surgery
• Cardiovascular Surgery
• Others

Global Hemostasis and Tissue Sealing Agents Market Size by End-use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Home Care Settings
• Others

Global Hemostasis and Tissue Sealing Agents Market Size & CAGR (2026-2033)

• North America (Product, Material, Application, End-use)
  • US
  • Canada
• Europe (Product, Material, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Material, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Material, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Material, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Behring (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferrosan Medical Devices A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohera Medical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marine Polymer Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Equimedical B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Medical Solutions Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohesion Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HyperBranch Medical Technology, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mil Laboratories Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations